Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, discusses which outpatient populations are at highest risk of influenza-associated complications and the recommended treatments for these individuals.
The nation’s top public health officials believes the disease is destined to spread across the United States in the coming months.
Vaccines are generally quite safe, but a recent study of BCG, DTP, and MCV raises concerns that warrant further exploration.
The United Nations Children’s Fund (UNICEF) has partnered with six vaccine makers and the Global Alliance for Vaccines and Immunization (GAVI) to offer 450 million doses of an inexpensive pentavalent vaccine for children.
Changes in strain prevalence indicate that the existing 9-valent HPV vaccines may offer some protection against an additional high-risk strain that is not included in the vaccine (strain 31), potentially due to antigenic similarities with other strains.
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses the 2016-2017 flu vaccine.
A mutated version of Yersinia pestis may hold the key to vaccines for the plague.
Researchers at Sanofi Pasteur, have developed a “transmission model” for Dengue and assessed the population impact of vaccination in the 10 countries participating in the Phase III efficacy studies for CYD-TDV/Dengvaxia.
The US Food and Drug Administration has approved its quadrivalent formulation of the Flublok influenza vaccine.
In the 10 years since the human papilloma virus (HPV) vaccine first became available, a series of new studies have come out showing just how effective the virus really is and how HPV vaccination rates can be improved in adolescents.
Researchers in a recent study investigated how mixed messages delivered by vaccine manufacturers may prevent women from receiving the safe and effective influenza vaccine during pregnancy.
Researchers recently studied the way people expressed their pro-vaccination and anti-vaccination opinions on Facebook to understand how people discuss and spread these views.
To assess factors associated with the likelihood that healthcare providers will accept seasonal influenza vaccine policy changes, Nova Scotia researchers examined the roles that their knowledge and attitude play in the matter.
Pharmacists are critical to expanding access to pandemic vaccination. However, little is known about the relationships and planning activities between public health programs and pharmacies.
The World Health Organization (WHO) recently met to establish new guidelines for the Southern Hemisphere’s 2017 influenza virus vaccine.
Recently, WHO published a paper outlining their decade-long initiative to increase access and regulate production of the influenza vaccine.
Thanks to the recently approved $1.1 billion in federal funding to support Zika virus-related efforts, various government agencies are ramping up efforts to develop novel vaccines designed to prevent infection.
Researchers at the University of Zurich and the University Hospital-Zurich have made a discovery that may contribute to the development of an effective HIV vaccine.
Kenneth Fife, MD, PhD, Professor of Medicine at Indiana University, School of Medicine, discusses whether or not his genital herpes vaccine, GEN-003, can protect against oral herpes.
The US Food and Drug Administration (FDA) is designating Sansaria PfSPZ, a malaria vaccine, to the “fast track” a move that will expedite the process for the drug, now in review.
A varicella outbreak that had occurred last year in Michigan is thought to be associated with riding on a school bus, which makes small, enclosed spaces, such as a school bus, a risk factor for both transmitting and acquiring airborne diseases.
A new, adaptable antibody, has been discovered by researchers at the Dana-Farber Cancer Institute that can mutate to neutralize a number of influenza strains.
Walgreens has partnered up again with the US Department of Health in an effort to improve rates of flu vaccination by providing over $10 million in free flu shot vouchers for Americans who are uninsured.
Nearly 900,000 people in the United States get pneumococcal pneumonia each year, resulting in about 400,000 hospitalizations annually.
An anxiously awaited vaccine for the fight against Zika may be available sooner rather than later—if its developers and federal health officials get their way.
